| 标题 |
Final clinical data of a phase 1 dose-escalation study of WVT078, a BCMA×CD3 bispecific antibody, alone and in combination with γ-secretase inhibitor WHG626 in patients with relapsed and/or refractory multiple myeloma |
| 网址 | |
| DOI | |
| 其它 |
期刊:Cancer 作者:Schjesvold F; Spencer A; Cohen YC; Ocio EM; Lopez-Pardo J; et al 出版日期:2026/04/01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)